Surgically Metabolic Resection of Pericardial Fat to Ameliorate Myocardial Mitochondrial Dysfunction in Acute Myocardial Infarction Obese Rats

• Published in: Journal of Korean medical science 2022, 37(9), , pp.1-12
• Main Authors: Kang, Ki-Woon, Ko, Ju-Young, Lee, Hyunghee, Shin, Seung Yong, Lee, Wang Soo, Hong, Joonhwa, Kim, Sang-Wook, Lee, Seong-Kyu, Oak, Min-Ho
• Format: Article
• Language: English
• Subjects: Original; 의학일반
• ISSN: 1011-8934; 1598-6357
• DOI: 10.3346/jkms.2022.37.e55

Pericardial fat (PF) is highly associated with cardiovascular disease but the effectiveness of surgical resection of PF is still unknown for myocardial mitochondrial structure and function in acute myocardial infarction (AMI) with obesity. The aim of this study was to demonstrate the difference in myocardial mitochondrial structure and function between obese AMI with additionally resected PF and those without resected PF. Obese rats with 12-week high fat diet (45 kcal% fat, n = 21) were randomly assigned into 3 groups: obese control, obese AMI and obese AMI with additionally resected PF. One week after developing AMI and additional resection of PF, echocardiogram, myocardial mitochondrial histomorphology, oxidative phosphorylation system (OXPHOS), anti-oxidative enzyme and sarcoplasmic reticulum Ca ATPase 2 (SERCA2) in the non-infarcted area were assessed between these groups. There was significant improvement of systolic function in AMI with PF resection compared with the AMI group in the echocardiogram. Even though the electron microscopic morphology for the mitochondria seems to be similar between the AMI with PF resection and AMI groups, there was an improved expression of PGC-1α and responsive OXPHOS including NDUFB3, NDUFB5 and SDHB are associated with the ATP levels in the AMI with PF resection compared with those in the AMI group. In addition, the expression levels of antioxidant enzymes (MnSOD) and SERCA2 were improved in the AMI with PF resection compared with those in the AMI group. Surgical resection of PF might ameliorate myocardial mitochondria dysfunction in obese AMI.